Table 2.

Summary of pathogenic variants

Variable	All patients (N = 146)	TMA recurrence (n = 33)	No recurrence (n = 113)
Tested for at ≥5 pathogenic variants with no mutation identified	62 (42.5)	11 (33.3)	51 (45.1)
Tested for ˂5 pathogenic variants and no mutation identified	16 (11.0)	2 (6.1)	14 (12.4)
Any pathogenic variant found	27 (18.5)	10 (30.3)	17 (15.0)
Anti-CFH antibody tested and positive	19 (13.0)	2 (6.1)	17 (15.0)
Any pathogenic variant found or anti-CFH antibody positive	42 (28.8)	12 (36.4)	30 (26.5)

All values n (%).